Stay updated with breaking news from Otcmkts hypmy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hypera (OTCMKTS:HYPMY – Get Rating) and Myovant Sciences (NYSE:MYOV – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings and valuation. Risk & Volatility Hypera has a beta of 0.8, suggesting that […] ....
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totalling 5,300 shares, a decline of 35.4% from the April 30th total of 8,200 shares. Based on an average trading volume of 32,000 shares, the short-interest ratio is presently […] ....
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 7,300 shares, a decrease of 50.0% from the March 15th total of 14,600 shares. Based on an average daily trading volume, of 116,500 shares, the […] ....
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) was the recipient of a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 23,000 shares, a growth of 303.5% from the January 31st total of 5,700 shares. Based on an average daily volume of 57,000 shares, the short-interest […] ....